Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News

Trump Administration Appeals Judge's Order Upending Kennedy's Vaccine Policies

The Trump administration on Wednesday appealed a federal judge's ruling blocking key elements of Health Secretary Robert F. Kennedy Jr.'s push to reshape U.S. vaccine...

Next-Gen Sequencing Detects Neoplastic Bile Duct Strictures

DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.

Drug-Resistant Salmonella Surfaces Risk of Backyard Poultry

Expert highlights need for better surveillance and smart antibiotic use to prevent future outbreaks.

Multiple Anti‑TNF Switches Durable, Safe in Paediatric IBD

Multiple intramolecular switches among anti-TNF agents in children with inflammatory bowel disease show no clinically meaningful decline in treatment durability or increase in adverse events.

FDA OKs Daraxonrasib Pancreatic Cancer Preapproval Access

FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase 3 trial.

NSAID Use Not Tied to Hospitalization in Ulcerative Colitis

Use of NSAIDs is not associated with an increased risk for disease-related hospitalization in ulcerative colitis, although a small increase is observed in Crohn’s disease.

Todays Updates

Practice-Changing Ovarian Cancer Updates From SGO 2026

Dr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.

Data Trends: Heart Failure

Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.

Missed Sexual Health Assessment May Limit Clinical Insight

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.

US Supreme Court Lets Abortion Pill Mail Delivery Restart for Now

The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...

When Retirement Triggers Risk: Substance Use in Older Adults

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Personalized Stimulation Boosts Outcomes in Essential Tremor

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Adjunctive CBD Improves Neuropsychiatric Symptoms in TSC

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

Todays Updates

Practice-Changing Ovarian Cancer Updates From SGO 2026

Dr Bradley Corr reviews data on the NRG-GY019 and ROSELLA trials, and discusses their clinical impact on ovarian cancer care.

Data Trends: Heart Failure

Up to 15 million Americans are at risk of heart failure, with mortality rates rising in the US.

Missed Sexual Health Assessment May Limit Clinical Insight

New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.

US Supreme Court Lets Abortion Pill Mail Delivery Restart for Now

The U.S. Supreme Court temporarily reinstated on Monday a federal rule allowing the abortion pill to be prescribed through telemedicine and dispensed through the mail,...

When Retirement Triggers Risk: Substance Use in Older Adults

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Personalized Stimulation Boosts Outcomes in Essential Tremor

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Adjunctive CBD Improves Neuropsychiatric Symptoms in TSC

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

Latest News

The Trump administration on Wednesday appealed a federal judge's ruling blocking key elements of Health Secretary Robert F. Kennedy Jr.'s push to reshape U.S. vaccine...

DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.

Expert highlights need for better surveillance and smart antibiotic use to prevent future outbreaks.

Multiple intramolecular switches among anti-TNF agents in children with inflammatory bowel disease show no clinically meaningful decline in treatment durability or increase in adverse events.

FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase 3 trial.

Use of NSAIDs is not associated with an increased risk for disease-related hospitalization in ulcerative colitis, although a small increase is observed in Crohn’s disease.

News All Time

Vitamin C’s Potential Use in Cancer Is Getting a Second Look

Decades after early trials seemed to close the book on vitamin C as a cancer treatment, a member of a group of determined researchers is receiving the therapy himself.

Education Gap Tied to Higher Risk for Young-Onset CRC Death

Researchers analyze trends in colorectal cancer mortality among adults aged 25-49 years in a study spanning about three decades.

Aspirin Unlikely to Cut Colorectal Cancer Incidence

A Cochrane Review finds aspirin likely results in little to no difference in colorectal cancer incidence at a follow-up of 5 years to less than 15 years.

Tumor Genomic Testing: Too Little, Too Late

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-Impact Exercise Linked to Anal Incontinence in Women

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre's Inflammatory Bowel Drug Shown to Reduce Disease Activity in Mid-stage Study

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Age and Visceral Fat May Trend Together: What to Know

Why fat that surrounds organs is more dangerous continues to be studied.

Vaccination Protects Young Men From HPV-Related Cancers

HPV-related cancers — including anal, penile, and oropharyngeal — are rare in people younger than 50, but new research suggests vaccinated boys could see cancer protection in their teens and 20s.

The Intersection Between Gut and Spine Health

Emerging research is showing more and more connection between the two.

IBD Flare Prediction Improved by Psychosocial Data

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.

Sacral Fracture Risk After Short-Course RT for Rectal Cancer

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

Heavy Drinking Tied to Young-Onset Pancreatic Cancer

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

How Gut Bacteria Could Trigger Memory Loss as We Age

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca's Liver Cancer Therapy Combo Slows Disease Progression in Late-stage Trial

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

Symptom-Based H pylori Testing Does Not Prevent Cancer

Most gastric cancers found in people diagnosed with H pylori may already be present at diagnosis, and treatment of the infection may not provide short-term protection.

Evidence Suggest Fewer GLP-1 Doses Maintain Weight Loss

Doctors have started to personalize GLP-1 dosing with surprising outcomes.

Recommended News For You

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

Atezolizumab Consolidation Impresses in High-Risk DLBCL

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

How to keep your prostate healthy and lower your risk of developing serious problems

What Comes After Cancer?

Study finds higher breast cancer rates in areas with more air pollution

Recommended Articles For You

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound 

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization 

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds 

Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemotherapy Boosts Survival for Older Patients With TNBC

2.

More People Than Previously Believed Have Schizophrenia.

3.

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

4.

Hereditary cancer has a rare and underreported cause.

5.

Q&A: Breast cancer facts that could save lives

1.

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification

2.

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment

3.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

4.

Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics

5.

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot